Stock Scorer

Adma Biologics, Inc. (ADMA) · Insider trading

What Adma Biologics's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months
$468,294
2 insiders, 5 trades
Sold, 12 months
$1.90M
2 insiders, 92% under a plan
Net, 12 months
−$1.43M
bought less sold
Latest filing
2026-07-28
filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

2024-11: $1.35M sold 2025-01 2025-03: $397,320 sold 2025-04: $450,660 sold 2025-05: $591,086 sold 2025-06: $9.90M sold 2025-07: $391,860 sold 2025-07 2025-08: $354,480 sold 2025-09: $338,730 sold 2025-10: $336,000 sold 2025-11: $336,000 sold 2025-12: $415,590 sold 2026-01 2026-02: $337,680 sold 2026-03: $217,420 bought 2026-03: $476,160 sold 2026-05: $250,874 bought 2026-07
Bought Sold Largest month: $9.90M

Who traded, two years

InsiderBoughtSold TradesLast tradeHolds after
Elms SteveDirector $217,420 $8.83M 5 2026-03-06 –
Grossman Adam SDirector, President and CEO – $5.56M 25 2026-03-16 2,118,777
Guiheen Lawrence P.Director – $601,836 3 2025-06-09 94,830
Grossman Jerrold BDirector $250,874 $213,100 4 2026-05-27 520,284
Tade Brad L.CFO and Treasurer – $317,250 1 2024-11-22 199,433
Kestenberg-Messina Kaitlin M.COO and SVP, Compliance – $157,800 1 2026-03-09 466,600

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

DateInsiderTradeShares PriceValueHolds afterFiling
2026-05-27 Grossman Jerrold BDirector Buy 6,400 7.91 $50,624 520,284 Form 4
2026-05-12 Grossman Jerrold BDirector Buy 12,500 8.01 $100,125 513,884 Form 4
2026-05-11 Grossman Jerrold BDirector Buy 12,500 8.01 $100,125 501,384 Form 4
2026-03-16 Grossman Adam SDirector, President and CEO Saleplan 15,000 15.16 $227,400 2,118,777 Form 4
2026-03-16 Grossman Adam SDirector, President and CEO Saleplan 6,000 15.16 $90,960 2,112,777 Form 4
2026-03-09 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Sale 10,096 15.63 $157,800 466,600 Form 4
2026-03-06 Elms SteveDirector Buyindirect 7,000 15.39 $107,730 2,045,730 Form 4
2026-03-05 Elms SteveDirector Buyindirect 7,000 15.67 $109,690 2,038,730 Form 4
2026-02-17 Grossman Adam SDirector, President and CEO Saleplan 15,000 16.08 $241,200 2,290,379 Form 4
2026-02-17 Grossman Adam SDirector, President and CEO Saleplan 6,000 16.08 $96,480 2,284,379 Form 4
2025-12-15 Grossman Adam SDirector, President and CEO Saleplan 15,000 19.79 $296,850 2,013,850 Form 4
2025-12-15 Grossman Adam SDirector, President and CEO Saleplan 6,000 19.79 $118,740 2,007,850 Form 4
2025-11-19 Grossman Adam SDirector, President and CEO Saleplan 15,000 16.00 $240,000 2,019,850 Form 4
2025-11-19 Grossman Adam SDirector, President and CEO Saleplan 6,000 16.00 $96,000 2,013,850 Form 4
2025-10-24 Grossman Adam SDirector, President and CEO Saleplan 15,000 16.00 $240,000 2,025,850 Form 4
2025-10-24 Grossman Adam SDirector, President and CEO Saleplan 6,000 16.00 $96,000 2,019,850 Form 4
2025-09-15 Grossman Adam SDirector, President and CEO Saleplan 15,000 16.13 $241,950 2,031,850 Form 4
2025-09-15 Grossman Adam SDirector, President and CEO Saleplan 6,000 16.13 $96,780 2,025,850 Form 4
2025-08-15 Grossman Adam SDirector, President and CEO Saleplan 15,000 16.88 $253,200 2,037,850 Form 4
2025-08-15 Grossman Adam SDirector, President and CEO Saleplan 6,000 16.88 $101,280 2,031,850 Form 4
2025-07-15 Grossman Adam SDirector, President and CEO Saleplan 15,000 18.66 $279,900 2,043,850 Form 4
2025-07-15 Grossman Adam SDirector, President and CEO Saleplan 6,000 18.66 $111,960 2,037,850 Form 4
2025-06-16 Grossman Adam SDirector, President and CEO Saleplan 15,000 20.81 $312,150 2,049,850 Form 4
2025-06-16 Grossman Adam SDirector, President and CEO Saleplan 6,000 20.81 $124,860 2,043,850 Form 4
2025-06-16 Elms SteveDirector Sale 194,749 20.24 $3.94M 87,330 Form 4
2025-06-13 Elms SteveDirector Sale 137,931 20.82 $2.87M 282,079 Form 4
2025-06-12 Elms SteveDirector Saleindirect 92,941 21.69 $2.02M 2,031,730 Form 4
2025-06-09 Guiheen Lawrence P.Director Sale 20,000 20.96 $419,200 94,830 Form 4
2025-06-09 Grossman Jerrold BDirector Sale 10,000 21.31 $213,100 478,194 Form 4
2025-05-22 Guiheen Lawrence P.Director Sale 1,221 20.12 $24,567 114,830 Form 4
2025-05-21 Guiheen Lawrence P.Director Sale 7,779 20.32 $158,069 114,830 Form 4
2025-05-15 Grossman Adam SDirector, President and CEO Saleplan 15,000 19.45 $291,750 2,055,850 Form 4
2025-05-15 Grossman Adam SDirector, President and CEO Saleplan 6,000 19.45 $116,700 2,049,850 Form 4
2025-04-15 Grossman Adam SDirector, President and CEO Saleplan 15,000 21.46 $321,900 2,061,850 Form 4
2025-04-15 Grossman Adam SDirector, President and CEO Saleplan 6,000 21.46 $128,760 2,055,850 Form 4
2025-03-19 Grossman Adam SDirector, President and CEO Saleplan 15,000 18.92 $283,800 2,067,850 Form 4
2025-03-19 Grossman Adam SDirector, President and CEO Saleplan 6,000 18.92 $113,520 2,061,850 Form 4
2024-11-22 Grossman Adam SDirector, President and CEO Sale 48,967 21.10 $1.03M 1,989,007 Form 4
2024-11-22 Tade Brad L.CFO and Treasurer Sale 15,000 21.15 $317,250 199,433 Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

34 × option exercise26 × shares withheld for tax18 × grant or award2 × gift1 × other
Show them
DateInsiderWhatShares PriceHolds afterFiling
2026-07-24 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −3,177 8.37 443,061 Form 4
2026-07-16 Kohler TerryCFO and Treasurer Grant or award A +85,130 – 143,149 Form 4
2026-04-01 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −20,362 9.11 446,238 Form 4
2026-03-17 Guiheen Lawrence P.Director Gift G −30,000 – 105,520 Form 4
2026-03-17 Guiheen Lawrence P.Director Gift G +30,000 – 30,000 Form 4
2026-03-16 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,133,777 Form 4
2026-03-13 Guiheen Lawrence P.Director Option exercise M +30,000 3.66 135,520 Form 4
2026-03-09 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Other J −91,266 – 466,600 Form 4
2026-03-09 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Option exercise M +2,500 5.00 469,100 Form 4
2026-03-09 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Option exercise M +1,250 4.31 470,350 Form 4
2026-03-09 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Option exercise M +2,646 2.83 472,996 Form 4
2026-03-09 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Option exercise M +1,525 2.35 474,521 Form 4
2026-03-09 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Option exercise M +2,175 1.55 476,696 Form 4
2026-03-07 Grossman Adam SDirector, President and CEO Shares withheld for tax F −29,513 15.39 2,118,777 Form 4
2026-03-07 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −4,235 15.39 557,866 Form 4
2026-03-06 Grossman Adam SDirector, President and CEO Shares withheld for tax F −56,438 15.39 2,148,290 Form 4
2026-03-06 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −10,059 15.39 562,101 Form 4
2026-02-26 Grossman Adam SDirector, President and CEO Shares withheld for tax F −54,858 15.18 2,204,728 Form 4
2026-02-19 Tade Brad L.CFO and Treasurer Shares withheld for tax F −6,479 16.32 232,940 Form 4
2026-02-19 Grossman Adam SDirector, President and CEO Shares withheld for tax F −24,793 16.32 2,259,586 Form 4
2026-02-19 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −8,161 16.32 572,160 Form 4
2026-02-17 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,305,379 Form 4
2026-02-09 Elms SteveDirector Grant or award A +10,690 – 98,020 Form 4
2026-02-09 Guiheen Lawrence P.Director Grant or award A +10,690 – 105,520 Form 4
2026-02-09 Salas Eduardo ReneDirector Grant or award A +10,690 – 21,579 Form 4
2026-02-09 Finger Alison CecilyDirector Grant or award A +10,690 – 45,619 Form 4
2026-02-09 Kwon YoungDirector Grant or award A +10,690 – 263,020 Form 4
2026-02-09 Grossman Adam SDirector, President and CEO Grant or award A +282,529 – 2,290,379 Form 4
2026-02-09 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Grant or award A +91,631 – 580,321 Form 4
2026-02-09 Grossman Jerrold BDirector Grant or award A +10,690 – 488,884 Form 4
2025-12-15 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,028,850 Form 4
2025-11-19 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,034,850 Form 4
2025-10-24 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,040,850 Form 4
2025-09-15 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,046,850 Form 4
2025-08-15 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,052,850 Form 4
2025-07-30 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Option exercise M +2,500 8.98 489,898 Form 4
2025-07-30 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −1,208 18.59 488,690 Form 4
2025-07-24 Tade Brad L.CFO and Treasurer Shares withheld for tax F −7,123 17.31 239,419 Form 4
2025-07-24 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −3,027 17.31 487,398 Form 4
2025-07-15 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,058,850 Form 4
2025-06-26 Tade Brad L.CFO and Treasurer Shares withheld for tax F −9,838 18.40 246,542 Form 4
2025-06-16 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,064,850 Form 4
2025-06-13 Elms SteveDirector Option exercise M +9,000 5.96 96,330 Form 4
2025-06-13 Elms SteveDirector Option exercise M +10,000 5.00 106,330 Form 4
2025-06-13 Elms SteveDirector Option exercise M +53,837 3.66 160,167 Form 4
2025-06-13 Elms SteveDirector Option exercise M +17,500 4.91 177,667 Form 4
2025-06-13 Elms SteveDirector Option exercise M +30,000 3.89 207,667 Form 4
2025-06-13 Elms SteveDirector Option exercise M +15,000 2.92 222,667 Form 4
2025-06-13 Elms SteveDirector Option exercise M +55,000 2.35 277,667 Form 4
2025-06-13 Elms SteveDirector Option exercise M +53,172 1.67 330,839 Form 4
2025-06-13 Elms SteveDirector Option exercise M +51,630 3.35 382,469 Form 4
2025-06-13 Elms SteveDirector Option exercise M +37,541 5.40 420,010 Form 4
2025-06-09 Grossman Jerrold BDirector Option exercise M +10,000 5.00 488,194 Form 4
2025-05-22 Guiheen Lawrence P.Director Option exercise M +1,221 5.96 116,051 Form 4
2025-05-21 Guiheen Lawrence P.Director Option exercise M +7,779 5.96 122,609 Form 4
2025-05-15 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,070,850 Form 4
2025-04-15 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,076,850 Form 4
2025-04-01 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −18,920 19.42 490,425 Form 4
2025-03-19 Grossman Adam SDirector, President and CEO Option exercise M +15,000 5.40 2,082,850 Form 4
2025-03-07 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −3,935 17.02 509,345 Form 4
2025-03-07 Grossman Adam SDirector, President and CEO Shares withheld for tax F −29,513 17.02 2,067,850 Form 4
2025-03-06 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −8,881 16.91 513,280 Form 4
2025-03-06 Grossman Adam SDirector, President and CEO Shares withheld for tax F −56,438 16.91 2,097,363 Form 4
2025-02-26 Tade Brad L.CFO and Treasurer Shares withheld for tax F −5,280 15.78 256,380 Form 4
2025-02-26 Grossman Adam SDirector, President and CEO Shares withheld for tax F −54,867 15.78 2,153,801 Form 4
2025-02-25 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −1,855 15.44 522,161 Form 4
2025-02-25 Grossman Adam SDirector, President and CEO Shares withheld for tax F −18,018 15.44 2,208,668 Form 4
2025-02-19 Grossman Adam SDirector, President and CEO Grant or award A +252,022 – 2,226,686 Form 4
2025-02-19 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Grant or award A +77,784 – 524,016 Form 4
2025-02-19 Tade Brad L.CFO and Treasurer Grant or award A +62,227 – 261,660 Form 4
2025-02-19 Finger Alison CecilyDirector Grant or award A +10,889 – 34,929 Form 4
2025-02-19 Grossman Jerrold BDirector Grant or award A +10,889 – 478,194 Form 4
2025-02-19 Salas Eduardo ReneDirector Grant or award A +10,889 – 10,889 Form 4
2025-02-19 Kwon YoungDirector Grant or award A −10,889 – 252,330 Form 4
2025-02-19 Elms SteveDirector Grant or award A +10,889 – 87,330 Form 4
2025-02-19 Guiheen Lawrence P.Director Grant or award A +10,889 – 164,830 Form 4
2025-01-30 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Option exercise M +5,000 10.80 449,587 Form 4
2025-01-30 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −3,355 16.10 446,232 Form 4
2024-12-31 Grossman Adam SDirector, President and CEO Shares withheld for tax F −14,343 17.15 1,974,664 Form 4
2024-12-31 Kestenberg-Messina Kaitlin M.COO and SVP, Compliance Shares withheld for tax F −1,854 17.15 444,587 Form 4
2024-11-27 Elms SteveDirector Option exercise M +9,000 10.80 2,124,671 Form 4

How to read it

Buy, sale
Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan
A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after
The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value
Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Adma Biologics's scores and multiples ›